North Central London Formulary


	North Central London Joint Formulary

Search

Formulary Chapter 13: Skin - Full Chapter

13.04

Topical corticosteriods.

Betamethasone dipropionate 0.05% - Topical
(Diprosone^®)
(Dermatology)

Formulary

Provider notes

NMUH:
- Diprosone cream and Diprosone ointment are FORMULARY.
- Diprosone lotion is NON-FORMULARY.
RFL:
- Diprosone cream and Diprosone ointment are FORMULARY
- Diprosone lotion is NON-FORMULARY
RNOH:
- Non-formulary
UCLH:
WH:
- Non-formulary

Betamethasone dipropionate 0.05% + Salicylic acid 3% - Topical
(Diprosalic^®)
(Dermatology)

Formulary

Provider notes

NMUH:
- No restriction stated
RFL:
- Ointment and Scalp Application available
RNOH:
- Non-formulary
UCLH:
WH:
- No restriction stated

Betamethasone dipropionate 0.064% + Clotrimazole 1% - Topical
(Lotriderm^®)
(Dermatology)

Restricted

Provider notes

NMUH:
- Restricted to Dermatology department use ONLY
RFL:
- Dermatology use only
RNOH:
- Non-formulary
UCLH:
WH:
- Non-formulary

Betamethasone valerate 0.025% - Topical
(Dermatology)

Formulary

Provider notes

NMUH:
- No restriction stated
RFL:
- cream and ointment available
RNOH:
- No restriction stated
UCLH:
WH:
- No restriction stated

Betamethasone valerate 0.1% - Topical
(Dermatology)

Formulary

Provider notes

NMUH:
- When Betnovate cream or ointment are requested/prescribed, the non-proprietary version, betamethasone valerate 0.1% cream or ointment will be supplied.
- When Betnovate scalp application is prescribed/requested, Betacap (betametasone valerate 0.1%) scalp application will be supplied.
- Bettamousse^® is NON-FORMULARY
RFL:

Cream, Ointment, Scalp application and Foam available

RNOH:

No restriction stated
Bettamousse® is not available

UCLH:
WH:
- No restriction stated
- Betacap^® and Bettamousse^® are not available

Betamethasone valerate 0.1% + Clioquinol 3% - Topical
(Dermatology)

Formulary

Provider notes

NMUH:

No restriction stated

RFL:

Cream and Ointment available

RNOH:

Non-formulary

UCLH:
WH:

Restricted to Dermatology only

Betamethasone valerate 0.1% + Fucidic acid 2% - Topical
(Dermatology)

Restricted

Provider notes

NMUH:
- Fucibet cream is FORMULARY
- Fucibet lipid cream is NON-FORMULARY
RFL:
- Cream available
RNOH:
- No restriction stated
UCLH:
WH:
- Restricted to Dermatology use ONLY
- Cream ONLY available

Betamethasone valerate 0.1% + Neomycin 0.5% - Topical
(Dermatology)

Formulary

Provider notes

NMUH:

No restriction stated

RFL:

Cream available

RNOH:

Non-formulary

UCLH:
WH:
- Non-formulary

Clobetasol propionate 0.05% - Topical
(Dermatology)

Formulary

Provider notes

NMUH:

No restriction stated

RFL:

Cream, Ointment and Scalp application (lotion) available

RNOH:

No restriction stated

UCLH:
WH:

No restriction stated

Clobetasol propionate 0.05% + Neomycin + Nystatin - Topical
(Dermatology)

Formulary

Provider notes

NMUH:

Non-formulary

RFL:

Cream and ointment available

RNOH:

Non-formulary

UCLH:
WH:

Non-formulary

Clobetasol propionate 0.05% shampoo
(Etrivex^®)
(Dermatology)

Formulary

Provider notes

NMUH:

For use SECOND LINE in topical treatment of MODERATE SCALP PSORIASIS in adults who have failed treatment with Dermovate 0.05% Scalp Application.

RFL:

Non-formulary

RNOH:

Non-formulary

UCLH:
WH:

Non-formulary

Clobetasone butyrate 0.05% - Topical
(Eumovate^®)
(Dermatology)

Formulary

Provider notes

NMUH:
- No restriction stated
RFL:
- No restriction stated
RNOH:
- No restriction stated
UCLH:
WH:
- No restriction stated

Clobetasone butyrate 0.05% + Oxytetracyline 3% + Nystatin - Topical
(Trimovate^®)
(Dermatology)

Formulary

Provider notes

NMUH:
- No restriction stated
RFL:
- No restriction stated
RNOH:
- No restriction stated
UCLH:
- Approved for Pruritus ani; Dermatitis - seborrhoeic - infected; Nappy rash; Infected intertrigo; Eczema - infected
WH:
- No restriction stated

Diflucortolone valerat 0.3% - Topical
(Nerisone Forte^®)
(Dermatology)

Formulary

Provider notes

NMUH:
- Non-formulary
RFL:
- Oily cream and ointment available
RNOH:
- Non-formulary
UCLH:
WH:
- Oily Cream ONLY

Diflucortolone valerate 0.1% - Topical
(Nerisone^®)
(Dermatology)

Formulary

Provider notes

NMUH:
- Non-formulary
RFL:
- Cream, oily cream and ointment are available
RNOH:
- Non-formulary
UCLH:
WH:
- No restriction stated

Flucinolone Acetonide 0.0025% - Topical
(Synalar 1 in 10 Dilution^®)

Formulary

Provider notes

NMUH:
- Non-formulary
RFL:
- No restriction stated
RNOH:
- No restriction stated
UCLH:
WH:
- Non-formulary

Fludroxycortide - topical
(Haelan^®)
(Dermatology)

Restricted

Provider notes

NMUH:
- Haelan tape is FORMULARY, for use on keloid scars only.
- Haelan cream and Haelan ointment are NON-FORMULARY.
RFL:
- Restricted to Dermatologists only
RNOH:
- Non-formulary
UCLH:
WH:
- Tape only

Fluocinolone acetonide 0.00625% - Topical
(Synalar 1 in 4 Dilution^®)
(Dermatology)

Formulary

Provider notes

NMUH:
- Non-formulary
RFL:
- cream and ointment
RNOH:
- Non-formulary
UCLH:
WH:
- Non-formulary

Fluocinolone acetonide 0.025% - Topical
(Synalar^®)
(Dermatology)

Formulary

Provider notes

NMUH:
- Non-formulary
RFL:
- Cream, ointment and gel available
RNOH:
- Non-formulary
UCLH:
WH:
- Gel 0.025% (Synalar) 30g ONLY

Fluocinolone acetonide 0.025% + Clioquinol 3%- Topical
(Synalar C^®)
(Dermatology)

Formulary

Provider notes

NMUH:
- No restriction stated
RFL:
- Cream and Ointment available
RNOH:
- Non-formulary
UCLH:
WH:
- Non-formulary

Fluocinonide 0.05% - Topical
(Metosyn^®)
(Dermatology)

Formulary

Provider notes

NMUH:
- Non-formulary
RFL:
- cream and ointment available
RNOH:
- Non-formulary
UCLH:
WH:
- Non-formulary

Fluticasone propionate - Topical
(Cutivate^®)
(Dermatology)

Restricted

Provider notes

NMUH:
- Non-formulary
RFL:
- Restricted to paediatrics only.
RNOH:
- Non-formulary
UCLH:
WH:
- Non-formulary

Hydrocortisone - Topical
(Dermatology)

Formulary

Provider notes

NMUH:
- Hydrocortisone 2.5% Ointment is FORMULARY.
- Hydrocortisone 2.5% cream is NON-FORMULARY.
- All other strength are available as both cream and ointment.
RFL:
- 2.5% cream available
- 0.5% and 1% available in both cream and ointment
RNOH:
- No restriction stated
UCLH:
WH:
- No restriction stated

Hydrocortisone 0.25% + Crotamiton 10% - Topical
(Eurax-Hydrocortisone^®)

Formulary

Provider notes

NMUH:

Non-formulary

RFL:

No restriction stated

RNOH:

Non-formulary

UCLH:
WH:

Non-formulary

Hydrocortisone 0.5% + Nystatin + Benzalkonium + Dimeticone - Topical
(Timodine^®)
(Dermatology)

Formulary

Provider notes

NMUH:
- No restriction stated
RFL:
- No restriction stated
RNOH:
- Non-formulary
- Store in a refrigerator
UCLH:
WH:
- Non-formulary

Hydrocortisone 1% + Clotrimazole 1% - Topical
(Canesten HC^®)
(Dermatology)

Formulary

Provider notes

NMUH:
- No restriction stated
RFL:
- No restriction stated
RNOH:
- No restriction stated
UCLH:
WH:
- Non-formulary

Hydrocortisone 1% + Miconazole 2% - Topical
(Daktacort^®)
(Dermatology)

Formulary

Provider notes

NMUH:
- Datkacort Cream is FORMULARY
- Daktacort Ointment is NON-FORMULARY
RFL:
- Both cream and ointment available
RNOH:
- Store Daktacort cream in the refrigerator
UCLH:
WH:
- No restriction stated

Hydrocortisone 1% + Nystatin + Chlorhexidine - Topical
(Nystaform-HC^®)
(Dermatology)

Formulary

Provider notes

NMUH:
- Non-formulary
RFL:
- Cream and ointment
RNOH:
- Non-formulary
UCLH:
WH:
- No restriction stated

Hydrocortisone 1% + Urea 10% - Topical
(Alphaderm^®)
(Dermatology)

Formulary

Provider notes

NMUH:
- No restriction stated
RFL:
- No restriction stated
RNOH:
- Non-formulary
UCLH:
WH:
- Non-formulary

Hydrocortisone Acetate 1% + Fusidic Acid 2% - Topical
(Fucidin H^®)
(Dermatology)

Formulary

Provider notes

NMUH:
- No restriction stated
RFL:
- No restriction stated
RNOH:
- No restriction stated
UCLH:
WH:
- Non-formulary

Hydrocortisone butyrate - Topical
(Locoid^®)
(Dermatology)

Formulary

Provider notes

NMUH:
- Non-formulary
RFL:
- cream, lipocream, ointment and scalp lotion available
RNOH:
- Non-formulary
UCLH:
WH:
- Cream 0.1% 30g, Ointment 0.1% 30g, Lotion 0.1% 30ml ONLY

Mometasone furoate 0.1% - Topical
(Dermatology)

Restricted

Provider notes

NMUH:
- No restriction stated
RFL:
- Cream, ointment and scalp application available
RNOH:
- No restriction stated
UCLH:
WH:
- Mometasone is restricted to Dermatology use only
- Cream 0.1% 30g, Ointment 0.1% 30g ONLY

Triamcinolone acetonide 0.1% + Chlortetracycline 3% - Topical
(Aureocort^®)
(Dermatology)

Restricted

Provider notes

NMUH:
- Non-formulary
RFL:
- Restricted to Dermatology Outpatients only
RNOH:
- Non-formulary
UCLH:
WH:
- Non-formulary

NICE TA81: Atopic dermatitis (eczema) - topical steroids

13.04

Topical corticosteriod preparation potencies

....

Non Formulary Items

Alclometasone dipopionate 0.05% - Topical
(Modrasone^®)
(Dermatology)

Non Formulary

Beclometasone dipropionate 0.025% - Topical
(Dermatology)

Non Formulary

Betamethasone valerate 2.25mg medicated plasters
(Betesil^®)
(Dermatology)

Non Formulary

Clobetasol propionate - Topical
(Clarelux^®)
(Dermatology)

Non Formulary

Flucinolone acetonide 0.025% + Neomycin 0.5% - Topical
(Synalar N^®)
(Dermatology)

Non Formulary

Fluocortolone 0.25% - Topical
(Ultralanum Plain^®)
(Dermatology)

Non Formulary

Hydrocortisone 0.1% - Topical
(Dioderm^®)

Non Formulary

Hydrocortisone 1% - Topical
(Mildison^®)

Non Formulary

Hydrocortisone 1% + Oxytetracyline 3% - Topical
(Terra-Cortril^®)
(Dermatology)

Non Formulary

Hydrocortisone 1%, Clioquinol 3%
(Vioform-Hydrocortisone^®)

Non Formulary

Hydrocortisone butyrate - Topical
(Locoid Crelo^®)
(Dermatology)

Non Formulary

Hydrocortisone Butyrate 0.1% with Chlorquinaldol 3%
(Locoid C^®)

Non Formulary

Key

	Notes
	Section Title (top level)
	Section Title (sub level)
	First Choice item
	Non Formulary section
	Restricted Drug
	Unlicensed
	Display tracking information
	Link to adult BNF
	Link to children's BNF
	Link to SPCs

Homecare

Traffic Light Status Information

Status	Description
	Medicines that should be initiated by a specialist. Prescribing can be transferred to primary care once the patient has been stabilised. Shared care: For drugs with regular, ongoing need for monitoring and/or assessment of efficacy or toxicity. Prior agreement must be obtained by the specialist from the primary care provider before prescribing responsibility is transferred. The shared care protocol must have been agreed by the relevant secondary care trust Drugs and Therapeutics Committee(s) (DTC) and approved by the North Central London JFC. Fact sheet: For drugs with some concerns surrounding safety or efficacy but do not require regular monitoring and/or monitoring of effectiveness/toxicity.
	Medicines which should normally be prescribed by specialists only (hospital only). For patients already receiving prescriptions in primary care - continue. No new patients to receive prescriptions in primary care. See link for the complete NCL Red List https://www.ncl-mon.nhs.uk/wp-content/uploads/2017/08/ncl_red_list.pdf
	Medicines not recommended for routine use in primary or secondary care. Medicines, which the North Central London JFC has actively reviewed and does not recommend for use at present due to limited clinical and/or cost effective data.